CSIMarket
 
Masimo Corp  (NASDAQ: MASI)
Other Ticker:  
 
 
Price: $161.2000 $-4.14 -2.504%
Day's High: $163.24 Week Perf: -6.21 %
Day's Low: $ 157.54 30 Day Perf: -0.22 %
Volume (M): 547 52 Wk High: $ 194.88
Volume (M$): $ 88,193 52 Wk Avg: $149.65
Open: $160.15 52 Wk Low: $101.61



 Market Capitalization (Millions $) 8,834
 Shares Outstanding (Millions) 55
 Employees 5,900
 Revenues (TTM) (Millions $) 1,974
 Net Income (TTM) (Millions $) -495
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 36

Masimo Corp
Masimo Corporation is a publicly traded medical technology company that was founded in 1989 by Joe Kiani. Its headquarters is located in Irvine, California, and it is considered one of the leading innovators in the healthcare industry. Masimo has a global presence and operates in over 130 countries.

Masimo's primary focus is on developing and manufacturing innovative solutions to improve patient outcomes and reduce healthcare costs. The company produces a range of products that include patient monitoring systems, pulse oximeters, sensors, and other medical devices. Masimo's products are used in hospitals, clinics, home healthcare settings, emergency medical services, military and veterinary settings.

One of Masimo's most famous inventions is the Signal Extraction Technology (SET), which is a patented technology that revolutionized pulse oximetry. Pulse oximetry is a non-invasive method of measuring a person's oxygen saturation levels, and SET technology significantly improves the accuracy and reliability of this measurement, preventing misdiagnosis and unnecessary interventions.

Masimo has received several prestigious awards and recognition for its innovative products and services. In 2021, Masimo was ranked as one of the World's Most Innovative Companies by Forbes, an accolade that the company has received multiple times in the past.

The company's growth has been fueled by its continuous investments in research and development. Masimo has a robust pipeline of new products and services in development that are designed to improve patient outcomes and quality of care while reducing healthcare delivery costs.

Furthermore, Masimo is also committed to sustainability and social responsibility. The company's sustainability program includes initiatives to reduce its carbon footprint, increase recycling, and minimize waste. It also supports various charitable organizations globally, providing life-saving medical equipment, supplies, and medicine to people in need.

Overall, Masimo Corporation is considered a trailblazer in the medical technology industry, with an exceptional track record of developing and delivering innovative solutions that revolutionize the healthcare industry. Its commitment to sustainability and social responsibility makes it a standout business in its field.


   Company Address: 52 Discovery Irvine, 92618 CA
   Company Phone Number: 297-7000   Stock Exchange / Ticker: NASDAQ MASI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BLCO        2.92% 
COO   -3.15%    
EW   -1.58%    
EYE        2.38% 
WRBY   -3.34%    
WST   -0.91%    
• View Complete Report
   



Business Update

Masimo Charts Course Amid Market Headwinds with Leadership and Strategy Updates,

Published Wed, Sep 25 2024 1:47 PM UTC

Masimo Provides Leadership and Business Updates Amid Market Challenges In an effort to steer through a period of market underperformance, Masimo Corporation has released several significant updates related to its leadership and business trajectory. Throughout this month, Masimo s shares have been trailing behind the broader market, creating concerns among investors and stake...

Business Update

Masimo Expands NICU Support, Enhances Clinical Trials, and Evaluates Consumer Business Separation,

Published Tue, Aug 27 2024 1:52 PM UTC

IRVINE, Calif. Masimo Corporation, globally recognized for their innovative advancements in medical monitoring technologies, has announced several strategic initiatives aimed at bolstering their influence across both clinical and consumer sectors. Combined, these efforts portray a company dedicated to leveraging its technological prowess in multifarious applications, from...

Announcement

Investor Rights Law Firm Investigates Potential Securities Claims Against Masimo Corporation (NASDAQ MASI)

Published Sun, Jun 23 2024 4:16 PM UTC

In recent news, investor rights law firm Rosen Law Firm has been investigating potential securities claims against Masimo Corporation (NASDAQ: MASI). The investigation stems from allegations that Masimo may have provided materially inaccurate business information to the investing public, which could have proven misleading for shareholders.Rosen Law Firm is a globally recogni...

Announcement

Masimo Corporation Faces Securities Investigation over Allegations of Misleading Business Information

Published Sat, Jun 15 2024 5:11 PM UTC

NEW YORK, June 15, 2024 - Rosen Law Firm, a prominent global investor rights law firm, is currently conducting an investigation into potential securities claims against Masimo Corporation (NASDAQ: MASI) following allegations of the company providing materially misleading business information to its shareholders.The investigation, initiated by Rosen Law Firm, aims to determin...

Business Update

Spanish Hospital Launches Innovative Remote Patient Monitoring Program with Masimos Wearable Medical Devices

Published Mon, Jun 3 2024 3:38 PM UTC

Germans Trias i Pujol, a cutting-edge hospital serving over 800,000 people north of Barcelona, Spain, has unveiled a groundbreaking telemedicine and remote patient management initiative using Masimo s advanced wearable medical technology. The SESHAT project leverages wearable devices and wireless connectivity, empowering doctors to remotely track patient data and provide per...







Masimo's Segments
Other    0.27 % of total Revenue
Healthcare    99.73 % of total Revenue

  Masimo Outlook

On February 25 2025 the Masimo provided following guidance

nnMasimo Corporation Reports Q4 and Full-Year 2024 Financial Results with Updated Expectations for 2025nn

IRVINE, California ? Masimo (Nasdaq: MASI) has released its financial results for the fourth quarter and the fiscal year that ended on December 28, 2024. Alongside these results, the company has provided revised guidance for the upcoming full year of 2025.

For the fourth quarter of 2024, Masimo reported consolidated revenue of $601 million, marking a 9% increase when evaluated both on a reported basis and a constant currency basis. Within this figure, the company's Healthcare segment generated $368 million in revenue, which corresponds to an 8% growth on a reported basis and a 9% increa...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com